speb/financial-data huggingface dataset:
Financial ratios for CASH.MC — quarterly report dated 2025-06-30
Total revenue: 575288235.2941177
Net income: 27956470.588235296
Capital expenditures: 1225882.3529411764
Operating cash flow: 47080000
Net tangible assets: -683275294.117647
Owner earnings: 26730588.23529412
Return on net tangible assets (%): -3.9121256783933447
Buffett classification: The Gruesome
Stock price: 0.9058823529411765
P/E ratio: 24.61439092667578
Shares outstanding: 1462546525
Book value: 209398823.5294118
P/B ratio: 6.327137206512761
Market cap (USD): 1324895087.3529413
Debt to equity: 7.282365764176437
Current ratio: 0.7240699123943655
Quick ratio: 0.7041183007998347
Effective tax rate (%): 45.33083818501063
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 29063529.411764707
Buyback yield (%): 0
Retained earnings: 915572941.1764706
Inventory turnover: 0
Receivables turnover: 1.3051177687329019
Capitalized R&D asset: 0
FCF margin (%): 5.051994396670723
Revenue growth (%): 2.550896429100609
Rule of 40 score: 7.602890825771332
Financial ratios for CASH.MC — quarterly report dated 2025-09-30
Total revenue: 568358823.5294118
Net income: 22396470.588235296
Capital expenditures: 19865882.352941178
Operating cash flow: 67625882.35294119
Net tangible assets: -604235294.117647
Owner earnings: 2530588.2352941185
Return on net tangible assets (%): -0.41880841121495344
Buffett classification: The Gruesome
Stock price: 0.8470588235294118
P/E ratio: 16.253243266785223
Shares outstanding: 1462546525
Book value: 227058823.5294118
P/B ratio: 5.456132113989637
Market cap (USD): 1238862938.8235295
Debt to equity: 8.152331606217615
Current ratio: 0.7247767721557432
Quick ratio: 0.7090445240843103
Effective tax rate (%): 43.03028489346421
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 47760000
Buyback yield (%): 0
Retained earnings: 192117647.05882353
Inventory turnover: 0
Receivables turnover: 1.1646697203471552
Capitalized R&D asset: 0
FCF margin (%): 8.403142174061538
Revenue growth (%): -1.2045112935715112
Rule of 40 score: 7.198630880490026
Financial ratios for CASH.MC — annual report dated 2025-12-31
Total revenue: 2338034117.647059
Gross profit: 806324705.882353
Operating income: 233785882.3529412
Net income: 110648235.29411764
Capital expenditures: 81929411.76470588
Operating cash flow: 246724705.88235295
Depreciation & amortization: 164094117.6470588
Net tangible assets: -619980000
Owner earnings: 192812941.17647058
Return on net tangible assets (%): -31.09986470151788
Capex to operating income (%): 35.04463611751326
Buffett classification: The Good
Stock price: 0.7411764705882353
P/E ratio: 9.796858201932993
Shares outstanding: 1462546525
Book value: 258945882.35294104
P/B ratio: 4.186222470968271
Market cap (USD): 1084005071.4705882
Debt to equity: 7.374245811071134
Current ratio: 0.928838370437363
Quick ratio: 0.9128513110671784
Effective tax rate (%): 44.37320715658731
Interest coverage ratio: 5.234104198493389
COGS to revenue (%): 65.51270574726178
SG&A to revenue (%): 9.192891564506935
Free cash flow (dilution-adjusted): 136703529.4117647
Buyback yield (%): 0.878875853468542
Retained earnings: 961497647.0588236
Inventory turnover: 50.72478279502863
Receivables turnover: 8.619686238110315
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.422615785897467
FCF margin (%): 5.8469433093363
Revenue growth (%): 7.399172533011542
Rule of 40 score: 13.246115842347841
Financial ratios for CASH.MC — quarterly report dated 2025-12-31
Total revenue: 1155569411.764706
Gross profit: 1018789411.7647059
Operating income: 117254117.64705883
Net income: 54691764.705882356
Capital expenditures: 22400000
Operating cash flow: 118489411.76470588
Net tangible assets: -619980000
Owner earnings: 32291764.705882356
Return on net tangible assets (%): -5.208517162792728
Capex to operating income (%): 19.103806714426184
Buffett classification: The Great
Stock price: 0.7411764705882353
P/E ratio: 8.280266638345939
Shares outstanding: 1462546525
Book value: 258945882.35294104
P/B ratio: 4.186222470968271
Market cap (USD): 1084005071.4705882
Debt to equity: 7.374245811071134
Current ratio: 0.928838370437363
Quick ratio: 0.9128513110671784
Effective tax rate (%): 43.576361495794444
Interest coverage ratio: 2.7058152793614596
COGS to revenue (%): 11.836588837283173
Free cash flow (dilution-adjusted): 67997647.05882353
Buyback yield (%): 0
Retained earnings: 961497647.0588236
Inventory turnover: 4.529668445864339
Receivables turnover: 4.260265357373664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.738224141332223
FCF margin (%): 5.884341205863368
Revenue growth (%): 103.31687728340628
Rule of 40 score: 109.20121848926965
Financial ratios for CMTV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.57
Shares outstanding: 5591253
Market cap (USD): 92647062.21000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMTV — annual report dated 2022-12-31
Total revenue: 39215361
Net income: 13739940
Capital expenditures: 615549
Operating cash flow: 15735245
Depreciation & amortization: 1141727
Net tangible assets: 63602094
Owner earnings: 14266118
Return on net tangible assets (%): 22.43026463877117
Buffett classification: The Gruesome
Stock price: 16.41
P/E ratio: 6.677792023109271
Shares outstanding: 5591253
Book value: 75176363
P/B ratio: 1.2204961515629587
Market cap (USD): 91752461.73
Debt to equity: 0.18871623252111838
Effective tax rate (%): 18.57941676297132
COGS to revenue (%): 0
SG&A to revenue (%): 30.64902551834216
Free cash flow (dilution-adjusted): 15119696
Buyback yield (%): 0
Retained earnings: 46464447
Receivables turnover: 12.20015885104588
Capitalized R&D asset: 0
FCF margin (%): 38.55554459896467
Rule of 40 score: 38.55554459896467
Financial ratios for CMTV — annual report dated 2023-12-31
Total revenue: 39318925
Net income: 13431855
Capital expenditures: 633462
Operating cash flow: 14930517
Depreciation & amortization: 1070035
Net tangible assets: 77454545
Owner earnings: 13868428
Return on net tangible assets (%): 17.90524752291812
Buffett classification: The Gruesome
Stock price: 15.92
P/E ratio: 6.626988436072307
Shares outstanding: 5591253
Book value: 89028814
P/B ratio: 0.9998195388742346
Market cap (USD): 89012747.76
Debt to equity: 0.7580354827595479
Effective tax rate (%): 17.73198122906758
COGS to revenue (%): 0
SG&A to revenue (%): 33.976674082518784
Free cash flow (dilution-adjusted): 14297055
Buyback yield (%): 0
Retained earnings: 54198230
Receivables turnover: 9.258487217899226
Capitalized R&D asset: 0
FCF margin (%): 36.36176472271305
Revenue growth (%): 0.26409039049774397
Rule of 40 score: 36.62585511321079
Financial ratios for CMTV — quarterly report dated 2024-09-30
Capital expenditures: 140911
Buffett classification: The Gruesome
Stock price: 14.85
Shares outstanding: 5591253
Market cap (USD): 83030107.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMTV — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.62
Shares outstanding: 5591253
Market cap (USD): 87335371.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMTV — annual report dated 2024-12-31
Total revenue: 39698953
Net income: 12764450
Capital expenditures: 791790
Operating cash flow: 15769153
Depreciation & amortization: 1029971
Net tangible assets: 86473936
Owner earnings: 13002631
Return on net tangible assets (%): 15.036474111690717
Buffett classification: The Gruesome
Stock price: 15.62
P/E ratio: 6.842078731163505
Shares outstanding: 5591253
Book value: 98048205
P/B ratio: 0.8907391202113286
Market cap (USD): 87335371.86
Debt to equity: 0.8718874557672932
Effective tax rate (%): 16.04036813593035
COGS to revenue (%): 0
SG&A to revenue (%): 39.475212356356096
Free cash flow (dilution-adjusted): 14977363
Buyback yield (%): 0
Retained earnings: 61623460
Receivables turnover: 8.876284803444358
Capitalized R&D asset: 0
FCF margin (%): 37.727350139435664
Revenue growth (%): 0.9665269332770416
Rule of 40 score: 38.69387707271271
Financial ratios for CMTV — quarterly report dated 2025-03-31
Total revenue: 10584175
Net income: 3525455
Capital expenditures: 274509
Operating cash flow: 382524
Depreciation & amortization: 256686
Net tangible assets: 91330761
Owner earnings: 3507632
Return on net tangible assets (%): 3.840581159725583
Buffett classification: The Gruesome
Stock price: 16.75
P/E ratio: 6.641234092478843
Shares outstanding: 5591253
Book value: 102905030
P/B ratio: 0.9100963067597375
Market cap (USD): 93653487.75
Debt to equity: 0.47604086991666006
Effective tax rate (%): 15.825447613535623
COGS to revenue (%): 0
SG&A to revenue (%): 36.251450868867906
Free cash flow (dilution-adjusted): 108015
Buyback yield (%): 0.037777557301916925
Retained earnings: 63777275
Receivables turnover: 1.9328832721434197
Capitalized R&D asset: 0
FCF margin (%): 1.020533012728909
Rule of 40 score: 1.020533012728909
Financial ratios for CMTV — quarterly report dated 2025-06-30
Total revenue: 11206587
Net income: 4059776
Capital expenditures: 111993
Operating cash flow: 4210182
Depreciation & amortization: 259882
Net tangible assets: 94769138
Owner earnings: 4207665
Return on net tangible assets (%): 4.439910596211185
Buffett classification: The Gruesome
Stock price: 19.25
P/E ratio: 14.189629854384133
Shares outstanding: 5591253
Book value: 106343407
P/B ratio: 1.0121137105377864
Market cap (USD): 107631620.25
Debt to equity: 0.6458980574131878
Effective tax rate (%): 16.787526130875847
COGS to revenue (%): 0
SG&A to revenue (%): 33.72934150245744
Free cash flow (dilution-adjusted): 4098189
Buyback yield (%): 0.4764752205799857
Retained earnings: 66462220
Receivables turnover: 2.522518704061434
Capitalized R&D asset: 0
FCF margin (%): 36.56946579721373
Revenue growth (%): 5.880590598700419
Rule of 40 score: 42.450056395914146
Financial ratios for CMTV — quarterly report dated 2025-09-30
Total revenue: 11786938
Net income: 4746787
Capital expenditures: 820208
Operating cash flow: 5764791
Depreciation & amortization: 265671
Net tangible assets: 100306073
Owner earnings: 4192250
Return on net tangible assets (%): 4.179457808103005
Buffett classification: The Gruesome
Stock price: 21.92
P/E ratio: 9.938378760069925
Shares outstanding: 5591253
Book value: 111880342
P/B ratio: 1.095458447561771
Market cap (USD): 122560265.76
Debt to equity: 0.5287972930937233
Effective tax rate (%): 17.501602855716218
COGS to revenue (%): 0
SG&A to revenue (%): 33.347261180130076
Free cash flow (dilution-adjusted): 4944583
Buyback yield (%): 0.1250421570561059
Retained earnings: 69843878
Receivables turnover: 2.642936839150202
Capitalized R&D asset: 0
FCF margin (%): 41.94968192757101
Revenue growth (%): 5.1786596579315365
Rule of 40 score: 47.12834158550254
Financial ratios for CMTV — annual report dated 2025-12-31
Total revenue: 46192810
Net income: 16967981
Capital expenditures: 780773
Operating cash flow: 16049032
Depreciation & amortization: 1045243
Net tangible assets: 102112709
Owner earnings: 17232451
Return on net tangible assets (%): 16.875912086516088
Buffett classification: The Gruesome
Stock price: 24.51
P/E ratio: 8.076483055349957
Shares outstanding: 5591253
Book value: 113686978
P/B ratio: 1.2054292711518817
Market cap (USD): 137041611.03
Debt to equity: 0.4297943604411756
Effective tax rate (%): 16.842275967900534
COGS to revenue (%): 0
SG&A to revenue (%): 35.721102483265256
Free cash flow (dilution-adjusted): 15268259
Buyback yield (%): 2.4687698681967256
Retained earnings: 73021908
Receivables turnover: 10.024535723392596
Capitalized R&D asset: 0
FCF margin (%): 33.05332366660526
Revenue growth (%): 16.35775381783998
Rule of 40 score: 49.411077484445244
Financial ratios for CMTV — quarterly report dated 2025-12-31
Total revenue: 12615111
Net income: 4635963
Capital expenditures: 0
Operating cash flow: 5691535
Depreciation & amortization: 263004
Net tangible assets: 102112709
Owner earnings: 4898967
Return on net tangible assets (%): 4.797607514261521
Buffett classification: The Gruesome
Stock price: 24.51
P/E ratio: 8.076483055349957
Shares outstanding: 5591253
Book value: 113686978
P/B ratio: 1.2054292711518817
Market cap (USD): 137041611.03
Debt to equity: 0.4297943604411756
Effective tax rate (%): 16.973413191840763
COGS to revenue (%): 0
SG&A to revenue (%): 37.43682477308364
Free cash flow (dilution-adjusted): 6117472
Buyback yield (%): 1.9569034396515732
Retained earnings: 73021908
Receivables turnover: 2.7376691496807166
Capitalized R&D asset: 0
FCF margin (%): 48.493207867929186
Revenue growth (%): 7.026192892505247
Rule of 40 score: 55.519400760434436
Financial ratios for CRMT — annual report dated 2022-04-30
Total revenue: 1190535000
Gross profit: 531920000
Operating income: 133703000
Net income: 95014000
Capital expenditures: 15776000
Operating cash flow: -119178000
Depreciation & amortization: 4033000
Net tangible assets: 468211000
Owner earnings: 83271000
Return on net tangible assets (%): 17.784930298519257
Capex to operating income (%): 11.799286478239082
Buffett classification: The Great
Stock price: 80.85
P/E ratio: 7.085951014061085
Shares outstanding: 8327329
Book value: 476934000
P/B ratio: 1.411651401766282
Market cap (USD): 673264549.65
Debt to equity: 1.052843789706752
Current ratio: 6.32057488837119
Quick ratio: 5.621062657736362
Effective tax rate (%): 22.522933909569044
Interest coverage ratio: 12.244985804560857
COGS to revenue (%): 55.320927146198976
SG&A to revenue (%): 13.114272154955545
Free cash flow (dilution-adjusted): -140470000
Buyback yield (%): 5.153694787292444
Retained earnings: 665410000
Inventory turnover: 5.712086520615427
Receivables turnover: 1.3702044254978283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.507209071145127
FCF margin (%): -11.798897134481557
Rule of 40 score: -11.798897134481557
Financial ratios for CRMT — annual report dated 2023-04-30
Total revenue: 1400413000
Gross profit: 599625000
Operating income: 64467000
Net income: 20432000
Capital expenditures: 22022000
Operating cash flow: -135728000
Depreciation & amortization: 5602000
Net tangible assets: 487131000
Owner earnings: 4012000
Return on net tangible assets (%): 0.8235977591243423
Capex to operating income (%): 34.16011292599314
Buffett classification: The Good
Stock price: 80.39
P/E ratio: 32.76399658917384
Shares outstanding: 8327329
Book value: 498947000
P/B ratio: 1.3416935632642344
Market cap (USD): 669433978.3100001
Debt to equity: 1.4047544127933427
Current ratio: 3.888215484046702
Quick ratio: 3.549927569428108
Effective tax rate (%): 20.787780103900133
Interest coverage ratio: 1.6826842764669032
COGS to revenue (%): 57.1822740862874
SG&A to revenue (%): 12.617420718031038
Free cash flow (dilution-adjusted): -163148000
Buyback yield (%): 0.7761781099186823
Retained earnings: 685802000
Inventory turnover: 7.327184554854058
Receivables turnover: 1.2980801494947323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.9053614236549725
FCF margin (%): -11.649991823840539
Revenue growth (%): 17.628881133272017
Rule of 40 score: 5.978889309431478
Financial ratios for CRMT — annual report dated 2024-04-30
Total revenue: 1393894000
Gross profit: 635348000
Operating income: 25650000
Net income: -31393000
Capital expenditures: 5830000
Operating cash flow: -73898000
Depreciation & amortization: 6871000
Net tangible assets: 456601000
Owner earnings: -30352000
Return on net tangible assets (%): -6.647379221683702
Capex to operating income (%): 22.72904483430799
Buffett classification: The Great
Stock price: 57.24
Shares outstanding: 8327329
Book value: 471150000
P/B ratio: 1.0116869616045847
Market cap (USD): 476656311.96000004
Debt to equity: 1.7394057094343627
Current ratio: 3.703721604639923
Quick ratio: 3.399961560094856
Interest coverage ratio: 0.3925139254453082
COGS to revenue (%): 54.41920260794579
SG&A to revenue (%): 12.871925698797757
Free cash flow (dilution-adjusted): -84218000
Buyback yield (%): 0.07657509002642349
Retained earnings: 654369000
Inventory turnover: 7.058211593933191
Receivables turnover: 1.2575095448082738
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.282343205691176
FCF margin (%): -6.041922843487382
Revenue growth (%): -0.465505533010619
Rule of 40 score: -6.507428376498001
Financial ratios for CRMT — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.04
Shares outstanding: 8327329
Market cap (USD): 325098924.15999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRMT — quarterly report dated 2025-01-31
Total revenue: 325726000
Gross profit: 156352000
Operating income: 21350000
Net income: 3162000
Capital expenditures: 751000
Operating cash flow: -30776000
Depreciation & amortization: 1890000
Net tangible assets: 535389000
Owner earnings: 4301000
Return on net tangible assets (%): 0.8033411220626497
Capex to operating income (%): 3.517564402810305
Buffett classification: The Great
Stock price: 48.69
P/E ratio: 32.057056373339655
Shares outstanding: 8327329
Book value: 558311000
P/B ratio: 0.7262218530711377
Market cap (USD): 405457649.01
Debt to equity: 1.547366969305638
Current ratio: 6.297763247538068
Quick ratio: 5.661009900814893
Effective tax rate (%): 27.97266514806378
Interest coverage ratio: 1.2615966436211075
COGS to revenue (%): 51.99891933711156
SG&A to revenue (%): 14.263522101398108
Free cash flow (dilution-adjusted): -30069000
Buyback yield (%): 0.004932697668630425
Retained earnings: 661636000
Inventory turnover: 1.1767558516809904
Receivables turnover: 0.2824373866265257
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5459173661912577
FCF margin (%): -9.231378520597067
Rule of 40 score: -9.231378520597067
Financial ratios for CRMT — quarterly report dated 2025-04-30
Total revenue: 370174000
Gross profit: 173278000
Operating income: 30026000
Net income: 10635000
Capital expenditures: 783000
Operating cash flow: 19218000
Depreciation & amortization: 1947000
Net tangible assets: 547020000
Owner earnings: 11799000
Return on net tangible assets (%): 2.156959526159921
Capex to operating income (%): 2.607739958702458
Buffett classification: The Great
Stock price: 47.42
P/E ratio: 9.282603224729666
Shares outstanding: 8327329
Book value: 569922000
P/B ratio: 0.6928701492134011
Market cap (USD): 394881941.18
Debt to equity: 1.4827818543590177
Current ratio: 3.829423384441727
Quick ratio: 3.5278014432186193
Effective tax rate (%): 14.769995191537106
Interest coverage ratio: 1.7283140505381915
COGS to revenue (%): 53.19012140236754
SG&A to revenue (%): 13.059534165014291
Free cash flow (dilution-adjusted): 17494000
Buyback yield (%): 0.0005064804923779321
Retained earnings: 672261000
Inventory turnover: 1.7544128522930793
Receivables turnover: 0.3115667386300032
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4324584875594324
FCF margin (%): 4.72588566457936
Revenue growth (%): 13.645825018573893
Rule of 40 score: 18.371710683153253
Financial ratios for CRMT — annual report dated 2025-04-30
Total revenue: 1390932000
Gross profit: 664877000
Operating income: 93750000
Net income: 17932000
Capital expenditures: 3848000
Operating cash flow: -48764000
Depreciation & amortization: 7647000
Net tangible assets: 547020000
Owner earnings: 21731000
Return on net tangible assets (%): 3.9726152608679755
Capex to operating income (%): 4.104533333333333
Buffett classification: The Great
Stock price: 47.42
P/E ratio: 22.02107635400402
Shares outstanding: 8327329
Book value: 569922000
P/B ratio: 0.6928701492134011
Market cap (USD): 394881941.18
Debt to equity: 1.4827818543590177
Current ratio: 3.829423384441727
Quick ratio: 3.5278014432186193
Effective tax rate (%): 21.35432656462436
Interest coverage ratio: 1.326963906581741
COGS to revenue (%): 52.19917292865504
SG&A to revenue (%): 13.582331846560436
Free cash flow (dilution-adjusted): -57362000
Buyback yield (%): 0.10990626684601126
Retained earnings: 672261000
Inventory turnover: 6.4694063031836695
Receivables turnover: 1.1707147095584987
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.594850569796069
FCF margin (%): -4.123997434813492
Revenue growth (%): -0.21249822439869892
Rule of 40 score: -4.336495659212191
Financial ratios for CRMT — quarterly report dated 2025-07-31
Total revenue: 341312000
Gross profit: 166232000
Operating income: 9649000
Net income: -5736000
Capital expenditures: 439000
Operating cash flow: -5918000
Depreciation & amortization: 2139000
Net tangible assets: 541536000
Owner earnings: -4036000
Return on net tangible assets (%): -0.7452874785794481
Capex to operating income (%): 4.5496942688361495
Buffett classification: The Great
Stock price: 45.04
P/E ratio: 46.52808561716908
Shares outstanding: 8327329
Book value: 565331000
P/B ratio: 0.6634394684883722
Market cap (USD): 375062898.15999997
Debt to equity: 1.502737334411168
Current ratio: 4.243933645763595
Quick ratio: 3.9093327382280743
Interest coverage ratio: 0.5661894143879826
COGS to revenue (%): 51.296174760922554
SG&A to revenue (%): 15.061878867429215
Free cash flow (dilution-adjusted): -7534000
Buyback yield (%): 0.018930158207680608
Retained earnings: 666515000
Inventory turnover: 1.5569448026251433
Receivables turnover: 0.28623903683489293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.758629419474345
FCF margin (%): -2.207364522782674
Revenue growth (%): -7.796873902543128
Rule of 40 score: -10.004238425325802
Financial ratios for CRMT — quarterly report dated 2025-10-31
Total revenue: 350192000
Gross profit: 171176000
Operating income: -7222000
Net income: -22472000
Capital expenditures: 687000
Operating cash flow: 9059000
Depreciation & amortization: 2102000
Net tangible assets: 531741000
Owner earnings: -21057000
Return on net tangible assets (%): -3.9600106066675314
Buffett classification: The Gruesome
Stock price: 22.24
Shares outstanding: 8327329
Book value: 555526000
P/B ratio: 0.33337737020409486
Market cap (USD): 185199796.95999998
Debt to equity: 1.733070999377167
Current ratio: 3.547390564649623
Quick ratio: 3.3065615228986576
Interest coverage ratio: -0.46043991074274787
COGS to revenue (%): 51.1193859368575
SG&A to revenue (%): 16.340179101749897
Free cash flow (dilution-adjusted): 7086000
Buyback yield (%): 0.1106912660623902
Retained earnings: 644033000
Inventory turnover: 1.7089669788355242
Receivables turnover: 0.29496037484912624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.562917004427262
FCF margin (%): 2.023461415452095
Revenue growth (%): 2.601725107819239
Rule of 40 score: 4.625186523271334
Financial ratios for CRMT — quarterly report dated 2026-01-31
Total revenue: 286792000
Gross profit: 143928000
Operating income: -14826000
Net income: -76703000
Capital expenditures: 241000
Operating cash flow: -5919000
Depreciation & amortization: 2040000
Net tangible assets: 456943000
Owner earnings: -74904000
Return on net tangible assets (%): -16.392416559614656
Buffett classification: The Gruesome
Stock price: 25.72
Shares outstanding: 8327329
Book value: 479817000
P/B ratio: 0.44637622651969394
Market cap (USD): 214178901.88
Debt to equity: 1.9844940883711915
Current ratio: 3.69758246752427
Quick ratio: 3.4421243987729286
Interest coverage ratio: -0.6808725602755453
COGS to revenue (%): 49.8144997071048
SG&A to revenue (%): 17.959705989009457
Free cash flow (dilution-adjusted): -7166000
Buyback yield (%): 0.010738686116191979
Retained earnings: 567320000
Inventory turnover: 1.4120065626914942
Receivables turnover: 0.25462565078733723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2046528558706717
FCF margin (%): -2.4986749979078913
Revenue growth (%): -18.10435418284827
Rule of 40 score: -20.60302918075616
Financial ratios for DAKT — annual report dated 2022-04-30
Total revenue: 610970000
Gross profit: 116697000
Operating income: 4046000
Net income: 592000
Capital expenditures: 19491000
Operating cash flow: -27035000
Depreciation & amortization: 15394000
Net tangible assets: 182165000
Owner earnings: -3505000
Return on net tangible assets (%): -1.9240798177476464
Capex to operating income (%): 481.73504695996047
Buffett classification: The Gruesome
Stock price: 3.35
P/E ratio: 273.23349222972973
Shares outstanding: 48284844
Book value: 191564000
P/B ratio: 0.8443873974233155
Market cap (USD): 161754227.4
Debt to equity: 0.012053412958593473
Current ratio: 1.486096942356828
Quick ratio: 0.8571976751803981
Effective tax rate (%): 46.57039711191336
COGS to revenue (%): 80.89971684370755
R&D to revenue (%): 4.74867833117829
SG&A to revenue (%): 13.68937918392065
Free cash flow (dilution-adjusted): -49384000
Buyback yield (%): 1.9684184155053495
Retained earnings: 96608000
Inventory turnover: 3.67784540746473
Receivables turnover: 4.179372994862744
Capitalized R&D asset: 29013000
ROCI (R&D-adjusted, %): 9.128983781884891
FCF margin (%): -8.082884593351555
Rule of 40 score: -8.082884593351555
Financial ratios for DAKT — annual report dated 2023-04-30
Total revenue: 754196000
Gross profit: 151355000
Operating income: 25964000
Net income: 6802000
Capital expenditures: 24563000
Operating cash flow: 15024000
Depreciation & amortization: 16993000
Net tangible assets: 196503000
Owner earnings: -768000
Return on net tangible assets (%): -0.39083372772934766
Capex to operating income (%): 94.6040671699276
Buffett classification: The Gruesome
Stock price: 4.81
P/E ratio: 34.144383951778885
Shares outstanding: 48284844
Book value: 200878000
P/B ratio: 1.1561748904310076
Market cap (USD): 232250099.64
Debt to equity: 0.09957785322434512
Current ratio: 1.6304344722905555
Quick ratio: 0.9193292825092904
Effective tax rate (%): 48.69125744889492
Interest coverage ratio: 23.03815439219166
COGS to revenue (%): 79.93160928989282
R&D to revenue (%): 3.976287331144689
SG&A to revenue (%): 12.649496947743028
Free cash flow (dilution-adjusted): -12388000
Buyback yield (%): 0
Retained earnings: 103410000
Inventory turnover: 4.033784326320861
Receivables turnover: 4.76407532104934
Capitalized R&D asset: 49427710
ROCI (R&D-adjusted, %): 11.805257167089868
Rosenberg metric: 1.194567952297246
FCF margin (%): -1.642543848018287
Revenue growth (%): 23.442394880272353
Rule of 40 score: 21.799851032254065
Financial ratios for DAKT — annual report dated 2024-04-30
Total revenue: 818083000
Gross profit: 222443000
Operating income: 87115000
Net income: 34621000
Capital expenditures: 16806000
Operating cash flow: 63241000
Depreciation & amortization: 19291000
Net tangible assets: 234726000
Owner earnings: 37106000
Return on net tangible assets (%): 15.808218944641839
Capex to operating income (%): 19.29174080238765
Buffett classification: The Great
Stock price: 9.45
P/E ratio: 13.179624384044365
Shares outstanding: 48284844
Book value: 238792000
P/B ratio: 1.9108335949278032
Market cap (USD): 456291775.79999995
Debt to equity: 0.23722737780160139
Current ratio: 2.090261887922786
Quick ratio: 1.3725766526604817
Effective tax rate (%): 35.9475310355035
Interest coverage ratio: 25.644686488077717
COGS to revenue (%): 72.80923818243382
R&D to revenue (%): 4.36899434409467
SG&A to revenue (%): 12.17309246127838
Free cash flow (dilution-adjusted): 44171000
Buyback yield (%): 0
Retained earnings: 138031000
Inventory turnover: 4.31598168222132
Receivables turnover: 4.708879193240163
Capitalized R&D asset: 65408920
ROCI (R&D-adjusted, %): 22.76218646932916
Rosenberg metric: 2.370469172029744
FCF margin (%): 5.399329896844208
Revenue growth (%): 8.470874944974515
Rule of 40 score: 13.870204841818722
Financial ratios for DAKT — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.03
Shares outstanding: 48284844
Market cap (USD): 629151517.3199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DAKT — quarterly report dated 2025-01-31
Total revenue: 149507000
Gross profit: 36781000
Operating income: -3628000
Net income: -17156000
Capital expenditures: 4114000
Operating cash flow: 12019000
Depreciation & amortization: 4913000
Net tangible assets: 268603000
Owner earnings: -16357000
Return on net tangible assets (%): -6.089656481871014
Buffett classification: The Gruesome
Stock price: 16.41
Shares outstanding: 48284844
Book value: 272291000
P/B ratio: 2.90995401992721
Market cap (USD): 792354290.04
Debt to equity: 0.1561527924169363
Current ratio: 2.4280894864502147
Quick ratio: 1.7342924685110628
COGS to revenue (%): 75.39847632552322
R&D to revenue (%): 6.314085628097681
SG&A to revenue (%): 20.714080277177658
Free cash flow (dilution-adjusted): 7244000
Buyback yield (%): 1.137874826114067
Retained earnings: 137335000
Inventory turnover: 1.000239576216293
Receivables turnover: 1.0513262263726373
Capitalized R&D asset: 9440000
ROCI (R&D-adjusted, %): 0.7181128611893948
FCF margin (%): 4.845258081561398
Rule of 40 score: 4.845258081561398
Financial ratios for DAKT — quarterly report dated 2025-04-30
Total revenue: 172551000
Gross profit: 43145000
Operating income: -17220000
Net income: -9425000
Capital expenditures: 4761000
Operating cash flow: 22874000
Depreciation & amortization: 4840000
Net tangible assets: 268175000
Owner earnings: -9346000
Return on net tangible assets (%): -3.485037755197166
Buffett classification: The Gruesome
Stock price: 12.69
Shares outstanding: 48284844
Book value: 271931000
P/B ratio: 2.253272596210068
Market cap (USD): 612734670.36
Debt to equity: 0.051597647932747646
Current ratio: 2.217673904828348
Quick ratio: 1.6023487689311358
COGS to revenue (%): 74.9957983436781
R&D to revenue (%): 5.7710474004786985
SG&A to revenue (%): 20.24155177309897
Free cash flow (dilution-adjusted): 16727000
Buyback yield (%): 3.3388024196476933
Retained earnings: 127910000
Inventory turnover: 1.2226683925585087
Receivables turnover: 1.2361715083998996
Capitalized R&D asset: 16282800
ROCI (R&D-adjusted, %): -3.954260998508511
Rosenberg metric: 0.6741525423728814
FCF margin (%): 9.693945558124845
Revenue growth (%): 15.413325128589298
Rule of 40 score: 25.107270686714145
Financial ratios for DAKT — annual report dated 2025-04-30
Total revenue: 756477000
Gross profit: 195487000
Operating income: 17638000
Net income: -10121000
Capital expenditures: 19217000
Operating cash flow: 97713000
Depreciation & amortization: 19547000
Net tangible assets: 268175000
Owner earnings: -9791000
Return on net tangible assets (%): -3.6509741773095925
Capex to operating income (%): 108.95226216124276
Buffett classification: The Gruesome
Stock price: 12.69
Shares outstanding: 48284844
Book value: 271931000
P/B ratio: 2.253272596210068
Market cap (USD): 612734670.36
Debt to equity: 0.051597647932747646
Current ratio: 2.217673904828348
Quick ratio: 1.6023487689311358
Interest coverage ratio: 6.139227288548556
COGS to revenue (%): 74.15823613936709
R&D to revenue (%): 5.136970456471247
SG&A to revenue (%): 16.326867836034673
Free cash flow (dilution-adjusted): 75275000
Buyback yield (%): 4.810238660509147
Retained earnings: 127910000
Inventory turnover: 5.300409111953061
Receivables turnover: 5.419472006304402
Capitalized R&D asset: 72703510
ROCI (R&D-adjusted, %): 5.360466313574454
Rosenberg metric: -0.7541827541827542
FCF margin (%): 9.950732143872186
Revenue growth (%): -7.5305317431116405
Rule of 40 score: 2.420200400760545
Financial ratios for DAKT — quarterly report dated 2025-07-31
Total revenue: 218972000
Gross profit: 65072000
Operating income: 23272000
Net income: 16470000
Capital expenditures: 4073000
Operating cash flow: 26097000
Depreciation & amortization: 4804000
Net tangible assets: 276059000
Owner earnings: 17201000
Return on net tangible assets (%): 6.230914405978432
Capex to operating income (%): 17.501718803712617
Buffett classification: The Great
Stock price: 16.22
P/E ratio: 11.887980717668487
Shares outstanding: 48284844
Book value: 279751000
P/B ratio: 2.799561644748365
Market cap (USD): 783180169.68
Debt to equity: 0.041397528516430686
Current ratio: 2.0688120028330386
Quick ratio: 1.5414476441934752
Effective tax rate (%): 25.887593934212305
COGS to revenue (%): 70.28295855177831
R&D to revenue (%): 4.873225800558976
SG&A to revenue (%): 14.215972818442541
Free cash flow (dilution-adjusted): 20859000
Buyback yield (%): 1.3600957241233913
Retained earnings: 144380000
Inventory turnover: 1.4060572838152665
Receivables turnover: 1.2913140653287964
Capitalized R&D asset: 20458060
ROCI (R&D-adjusted, %): 6.672281573852869
Rosenberg metric: 2.201948182365937
FCF margin (%): 9.525875454395996
Revenue growth (%): 26.902770775017242
Rule of 40 score: 36.42864622941324
Financial ratios for DAKT — quarterly report dated 2025-10-31
Total revenue: 229253000
Gross profit: 61825000
Operating income: 21563000
Net income: 17481000
Capital expenditures: 2389000
Operating cash flow: 16507000
Depreciation & amortization: 4784000
Net tangible assets: 293852000
Owner earnings: 19876000
Return on net tangible assets (%): 6.76394919891646
Capex to operating income (%): 11.079163381718685
Buffett classification: The Great
Stock price: 18.79
P/E ratio: 123.1034218127544
Shares outstanding: 48284844
Book value: 297451000
P/B ratio: 3.0501568956231444
Market cap (USD): 907272218.76
Debt to equity: 0.03798608846499087
Current ratio: 2.23326723627794
Quick ratio: 1.7084496952960353
Effective tax rate (%): 20.039337663525753
COGS to revenue (%): 73.03197777128325
R&D to revenue (%): 4.555665574714399
SG&A to revenue (%): 13.00659097154672
Free cash flow (dilution-adjusted): 13026000
Buyback yield (%): 0.17227464565554598
Retained earnings: 161861000
Inventory turnover: 1.6559977844595664
Receivables turnover: 1.3659346028265689
Capitalized R&D asset: 20879710
ROCI (R&D-adjusted, %): 5.74820512631249
Rosenberg metric: -0.30428263517945836
FCF margin (%): 5.681932188455549
Revenue growth (%): 4.695120837367335
Rule of 40 score: 10.377053025822883
Financial ratios for DAKT — quarterly report dated 2026-01-31
Total revenue: 181871000
Gross profit: 43629000
Operating income: 1922000
Net income: 3010000
Capital expenditures: 3380000
Operating cash flow: 11718000
Depreciation & amortization: 5150000
Net tangible assets: 286657000
Owner earnings: 4780000
Return on net tangible assets (%): 1.6674980900518739
Capex to operating income (%): 175.85848074921958
Buffett classification: The Gruesome
Stock price: 23.15
P/E ratio: 40.59391845583963
Shares outstanding: 48284844
Book value: 293738000
P/B ratio: 3.805412097175033
Market cap (USD): 1117794138.6
Debt to equity: 0.037625366823495765
Current ratio: 2.22282778926267
Quick ratio: 1.6820146588987033
Effective tax rate (%): 14.29384965831435
COGS to revenue (%): 76.01101879903888
R&D to revenue (%): 5.78871837731139
SG&A to revenue (%): 17.143469822016705
Free cash flow (dilution-adjusted): 6397000
Buyback yield (%): 0.944896706403252
Retained earnings: 164871000
Inventory turnover: 1.3344337619213098
Receivables turnover: 1.0900465696116801
Capitalized R&D asset: 21046910
ROCI (R&D-adjusted, %): 0.5061188635449005
Rosenberg metric: -1.7422443508234393
FCF margin (%): 3.5173282161532073
Revenue growth (%): -20.667995620558948
Rule of 40 score: -17.15066740440574
Financial ratios for EMC.AX — annual report dated 2021-06-30
Operating income: -2560064.661654135
Net income: -2546964.661654135
Capital expenditures: 1279736.8421052631
Depreciation & amortization: 6064.661654135338
Net tangible assets: 6222555.639097744
Owner earnings: -3820636.842105263
Return on net tangible assets (%): -61.39980200577598
Buffett classification: The Gruesome
Stock price: 0.10526315789473685
Shares outstanding: 269707017
Book value: 6222555.639097745
P/B ratio: 4.562468214411336
Market cap (USD): 28390212.315789476
Debt to equity: 0
Current ratio: 29.19669125988039
Quick ratio: 29.19669125988039
Free cash flow (dilution-adjusted): -1955515.789473684
Buyback yield (%): 1.184716779435622
Retained earnings: -13568209.77443609
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.14169177642481
Rule of 40 score: 0
Financial ratios for EMC.AX — annual report dated 2022-06-30
Operating income: -599269.6551724138
Net income: -581726.2068965518
Capital expenditures: 572205.5172413794
Depreciation & amortization: 6250.344827586207
Net tangible assets: 5126631.0344827585
Owner earnings: -1147681.3793103448
Return on net tangible assets (%): -22.386658442763043
Buffett classification: The Gruesome
Stock price: 0.06896551724137931
Shares outstanding: 269707017
Book value: 5126631.0344827585
P/B ratio: 3.6282080387536886
Market cap (USD): 18600483.931034483
Debt to equity: 0
Current ratio: 9.38517095570208
Quick ratio: 9.38517095570208
Free cash flow (dilution-adjusted): -1064344.8275862068
Buyback yield (%): 0
Retained earnings: -13027049.655172415
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.68934630055498
Rule of 40 score: 0
Financial ratios for EMC.AX — annual report dated 2023-06-30
Operating income: -1682224.5033112583
Net income: -1594307.284768212
Capital expenditures: 14817.218543046358
Depreciation & amortization: 32949.00662251656
Net tangible assets: 6080401.986754967
Owner earnings: -1576175.4966887417
Return on net tangible assets (%): -25.922225210144806
Buffett classification: The Gruesome
Stock price: 0.12582781456953643
Shares outstanding: 269707017
Book value: 6080401.986754967
P/B ratio: 5.581315938831597
Market cap (USD): 33936644.52317881
Debt to equity: 0.003848865429884548
Current ratio: 5.02504866674003
Quick ratio: 5.02504866674003
Free cash flow (dilution-adjusted): -1249541.7218543047
Buyback yield (%): 0.2856179225575612
Retained earnings: -14103725.82781457
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.64187856812279
Rule of 40 score: 0
Financial ratios for ESS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 297.62
Shares outstanding: 64261739
Market cap (USD): 19125578761.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESS — annual report dated 2022-12-31
Total revenue: 1606814000
Gross profit: 1098841000
Operating income: 513181000
Net income: 432985000
Capital expenditures: 163193000
Operating cash flow: 975649000
Depreciation & amortization: 539319000
Net tangible assets: 5716372000
Owner earnings: 809111000
Return on net tangible assets (%): 14.15427477427991
Capex to operating income (%): 31.80028099247634
Buffett classification: The Good
Stock price: 185.24
P/E ratio: 27.49251020788249
Shares outstanding: 64261739
Book value: 5922266000
P/B ratio: 2.0100151753332254
Market cap (USD): 11903844532.36
Debt to equity: 1.0176645223297973
Current ratio: 0.6629807186700832
Quick ratio: 0.6629807186700832
Effective tax rate (%): -2.3640541820155434
Interest coverage ratio: 2.2926446805278817
COGS to revenue (%): 31.613677749882683
SG&A to revenue (%): 3.5210671552525685
Free cash flow (dilution-adjusted): 805250000
Buyback yield (%): 1.5964590219855932
Retained earnings: -1080176000
Receivables turnover: 15.593323305352031
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.282558875264269
FCF margin (%): 50.11469902552504
Rule of 40 score: 50.11469902552504
Financial ratios for ESS — annual report dated 2023-12-31
Total revenue: 1669395000
Gross profit: 1138044000
Operating income: 525435000
Net income: 430708000
Capital expenditures: 140371000
Operating cash flow: 980064000
Depreciation & amortization: 548438000
Net tangible assets: 5422746000
Owner earnings: 838775000
Return on net tangible assets (%): 15.467716909477227
Capex to operating income (%): 26.715197883658305
Buffett classification: The Good
Stock price: 225.94
P/E ratio: 33.710303290535585
Shares outstanding: 64261739
Book value: 5626183000
P/B ratio: 2.580665667942191
Market cap (USD): 14519297309.66
Debt to equity: 1.1145791027415923
Current ratio: 1.8787827245538689
Quick ratio: 1.8787827245538689
Interest coverage ratio: 2.4679317066297175
COGS to revenue (%): 31.82895599902959
SG&A to revenue (%): 3.802215772779959
Free cash flow (dilution-adjusted): 831662000
Buyback yield (%): 0.6612165723483496
Retained earnings: -1267536000
Receivables turnover: 9.560104454790661
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.375462998739577
FCF margin (%): 49.81816765954133
Revenue growth (%): 3.894725836344468
Rule of 40 score: 53.7128934958858
Financial ratios for ESS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 276.77
Shares outstanding: 64261739
Market cap (USD): 17785721503.03
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESS — annual report dated 2024-12-31
Total revenue: 1774450000
Gross profit: 1207635000
Operating income: 528513000
Net income: 811306000
Capital expenditures: 136395000
Operating cash flow: 1068305000
Depreciation & amortization: 580220000
Net tangible assets: 5537046000
Owner earnings: 1255131000
Return on net tangible assets (%): 22.667881032593915
Capex to operating income (%): 25.80731221370146
Buffett classification: The Good
Stock price: 267.42
P/E ratio: 21.181741837703655
Shares outstanding: 64261739
Book value: 5751239000
P/B ratio: 2.988029925965518
Market cap (USD): 17184874243.38
Debt to equity: 1.1569837386344055
Current ratio: 0.6641997277947226
Quick ratio: 0.6641997277947226
Interest coverage ratio: 2.2439402366587555
COGS to revenue (%): 31.94313731015244
SG&A to revenue (%): 5.5736707148693965
Free cash flow (dilution-adjusted): 924752000
Buyback yield (%): 0.001722444958327384
Retained earnings: -1155662000
Receivables turnover: 8.58441457916074
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.263275339426212
FCF margin (%): 52.1148524895038
Revenue growth (%): 6.292998361681927
Rule of 40 score: 58.40785085118572
Financial ratios for ESS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 267.42
Shares outstanding: 64261739
Market cap (USD): 17184874243.38
Buyback yield (%): 0.001722444958327384
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ESS — quarterly report dated 2025-03-31
Total revenue: 464583000
Gross profit: 313630000
Operating income: 146214000
Net income: 212778000
Capital expenditures: 27914000
Operating cash flow: 281503000
Depreciation & amortization: 151287000
Net tangible assets: 5570001000
Owner earnings: 336151000
Return on net tangible assets (%): 6.035025846494462
Capex to operating income (%): 19.09119509759667
Buffett classification: The Great
Stock price: 292.16
P/E ratio: 22.059035316433093
Shares outstanding: 64261739
Book value: 5779951000
P/B ratio: 3.2482472024832045
Market cap (USD): 18774709666.24
Debt to equity: 1.1841624608928345
Current ratio: 1.0050983180227882
Quick ratio: 0.7427617916144362
Interest coverage ratio: 2.330772173691258
COGS to revenue (%): 32.492148873290674
SG&A to revenue (%): 3.5068007223682316
Free cash flow (dilution-adjusted): 251631000
Buyback yield (%): 0
Retained earnings: -1117971000
Inventory turnover: 1.3457159922619526
Receivables turnover: 3.474193114175466
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1459975517816674
FCF margin (%): 54.162765318576014
Rule of 40 score: 54.162765318576014
Financial ratios for ESS — quarterly report dated 2025-06-30
Total revenue: 469833000
Gross profit: 322416000
Operating income: 153758000
Net income: 231526000
Capital expenditures: 36536000
Operating cash flow: 216129000
Depreciation & amortization: 151501000
Net tangible assets: 5635249000
Owner earnings: 346491000
Return on net tangible assets (%): 6.148636910276725
Capex to operating income (%): 23.76201563495883
Buffett classification: The Great
Stock price: 272.53
P/E ratio: 39.417272249788425
Shares outstanding: 64261739
Book value: 5838836000
P/B ratio: 2.999442308307683
Market cap (USD): 17513251729.67
Debt to equity: 1.166794203502205
Current ratio: 0.4449041944570313
Quick ratio: 0.3817674009417588
Interest coverage ratio: 2.3560111550366214
COGS to revenue (%): 31.376467808774606
SG&A to revenue (%): 3.6517230590443837
Free cash flow (dilution-adjusted): 177349000
Buyback yield (%): 0
Retained earnings: -1062146000
Inventory turnover: 3.09355129792458
Receivables turnover: 3.402220194647202
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2373164561688463
FCF margin (%): 37.74724210517354
Revenue growth (%): 1.1300456538444152
Rule of 40 score: 38.87728775901795
Financial ratios for ESS — quarterly report dated 2025-09-30
Total revenue: 473303000
Gross profit: 317651000
Operating income: 150062000
Net income: 172724000
Capital expenditures: 36360000
Operating cash flow: 342589000
Depreciation & amortization: 151489000
Net tangible assets: 5631316000
Owner earnings: 287853000
Return on net tangible assets (%): 5.111647082138527
Capex to operating income (%): 24.229984939558317
Buffett classification: The Great
Stock price: 259.91
P/E ratio: 27.068898953515887
Shares outstanding: 64261739
Book value: 5831273000
P/B ratio: 2.8642576987031823
Market cap (USD): 16702268583.490002
Debt to equity: 1.1514319429050912
Current ratio: 0.5419452943745297
Quick ratio: 0.5419452943745297
Interest coverage ratio: 2.320785648004949
COGS to revenue (%): 32.88633285654222
SG&A to revenue (%): 3.815314925111398
Free cash flow (dilution-adjusted): 303767000
Buyback yield (%): 0
Retained earnings: -1063135000
Receivables turnover: 2.135574024942697
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2055843374781336
FCF margin (%): 64.18023971958766
Revenue growth (%): 0.7385602969565782
Rule of 40 score: 64.91880001654424
Financial ratios for ESS — annual report dated 2025-12-31
Total revenue: 1887345000
Gross profit: 1279307000
Operating income: 601913000
Net income: 702773000
Capital expenditures: 140348000
Operating cash flow: 1074423000
Depreciation & amortization: 607542000
Net tangible assets: 5541372000
Owner earnings: 1169967000
Return on net tangible assets (%): 21.113309122722676
Capex to operating income (%): 23.316990993715038
Buffett classification: The Great
Stock price: 254.1
P/E ratio: 23.234967592522764
Shares outstanding: 64261739
Book value: 5736895000
P/B ratio: 2.8462971485272086
Market cap (USD): 16328907879.9
Debt to equity: 1.194331777032698
Current ratio: 0.774781320272897
Quick ratio: 0.774781320272897
Interest coverage ratio: 2.3293486168944755
COGS to revenue (%): 32.21657937473011
SG&A to revenue (%): 3.8121276184269437
Free cash flow (dilution-adjusted): 924435000
Buyback yield (%): 0.002394526338661631
Retained earnings: -1148195000
Receivables turnover: 13.32955484458758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.724882227848069
FCF margin (%): 48.980710998784005
Revenue growth (%): 6.362253092507538
Rule of 40 score: 55.34296409129154
Financial ratios for ESS — quarterly report dated 2025-12-31
Total revenue: 479626000
Gross profit: 325842000
Operating income: 151879000
Net income: 85745000
Capital expenditures: 39538000
Operating cash flow: 234202000
Depreciation & amortization: 153265000
Net tangible assets: 5541372000
Owner earnings: 199472000
Return on net tangible assets (%): 3.599686142709784
Capex to operating income (%): 26.032565397454555
Buffett classification: The Good
Stock price: 254.1
P/E ratio: 23.234967592522764
Shares outstanding: 64261739
Book value: 5736895000
P/B ratio: 2.8462971485272086
Market cap (USD): 16328907879.9
Debt to equity: 1.194331777032698
Current ratio: 0.774781320272897
Quick ratio: 0.774781320272897
Interest coverage ratio: 2.3099467680608363
COGS to revenue (%): 32.06331600038364
SG&A to revenue (%): 4.261862367761547
Free cash flow (dilution-adjusted): 191688000
Buyback yield (%): 0
Retained earnings: -1148195000
Receivables turnover: 3.3874045666744355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1922161307088184
FCF margin (%): 39.96614028430485
Revenue growth (%): 1.3359306828817903
Rule of 40 score: 41.30207096718664
Financial ratios for FNF — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.28
Shares outstanding: 269157540
Market cap (USD): 10841665711.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0